India’s pharmaceutical retail market rebounded in November with double-digit growth, driven by increased demand for dermatological and cardiac medications. Respiratory issues, exacerbated by pollution, boosted Foracort sales to Rs 82 crore. Both acute and chronic medications saw 11% growth, and industry volumes rose by 3.5%. Analysts predict continued growth in 2025, fueled by price increases and new drug launches.